Current trials
Inflammatory Bowel Disease (Crohn's & Ulcerative Colitis)
New-generation therapies for Crohn's disease and ulcerative colitis.
Register your interest
What is IBD: Crohn's & UC?
Inflammatory bowel disease (IBD) covers Crohn's disease and ulcerative colitis — chronic conditions where the immune system inflames the digestive tract. Clinical trials give access to new-generation therapies aiming for deeper, longer-lasting remission.
Common signs and symptoms
- Persistent diarrhoea, sometimes with blood
- Abdominal pain and cramping
- Urgency to open bowels
- Fatigue
- Weight loss
- Flares despite current medication
Could I be eligible?
You may be suitable for a current or future research study if you:
- Are 18 years or older
- Have been diagnosed with Crohn's disease or ulcerative colitis
- Have active symptoms, or are not fully controlled on current treatment
- Have had a colonoscopy previously
- Can attend regular study visits
Registering your interest does not guarantee eligibility or enrolment in a clinical trial. A member of our research team will contact you to discuss further.
Before you decide
- Independently approved
- Every study is reviewed and approved by an independent Human Research Ethics Committee before it opens to participants.
- Entirely voluntary
- You can withdraw at any time, without giving a reason, and without affecting your ongoing care.
- No referral needed
- You can register your interest yourself. We will let your treating doctor know only if you want us to.
- Questions first, decisions later
- A research coordinator talks you through what the study involves and answers your questions before you commit to anything.